GL1X · GenesisL1 explorer

Research workbench

Structure of monoclinic lysozyme obtained by multi crystal data collection

Analyse Structure of monoclinic lysozyme obtained by multi crystal data collection in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5A3Z
Type
protein
Length
258 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysozyme
EC
3.2.1.17
UniProt
B8YK79
Ligands
NO3
Pockets
3 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BLysozyme (EC 3.2.1.17)protein12941% helix, 11% strandB8YK79

Ligands and binding sites

  • NO3 · Nitrate ion · ion · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12790.560.7733empty
2670.320.7517empty
3570.310.7616empty

Interfaces

1 interface between chains.

  • A–B · 196 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 5A3Z · Structure of monoclinic Lysozyme obtained by multi crystal data collection · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.